Post Categories
The Value of a Startup Incubator
January 20, 2020
Building a successful company from scratch will always be difficult, but it helps to begin the journey in an affordable, welcoming space that provides…
Aiding in the Development of Cardiovascular Drugs
January 13, 2020
According to the World Health Organization, cardiovascular disease is the leading cause of death in the United States and worldwide. In fact, about 17.9…
QPS CEO Dr. Benjamin Chien Featured in Innovation Delaware
January 1, 2020
The story of QPS‘s origin was recently included in the 2019/2020 issue of Innovation Delaware: Showcasing Delaware’s Innovators, which is a supplement to Delaware Business Times. In the…
QPS Physician Nutte Van Belzen Wins 2019 Young Entrepreneur Award
December 20, 2019
Entrepreneur Nutte Van Belzen of CC Diagnostics recently won the 2019 Jonge Ondernemingsprijs (Young Entrepreneur Award). Van Belzen also happens to work as a…
Small Molecule Drug Discovery Opening Doors for Chronic Disease Management
November 4, 2019
Although large molecule drug discovery has become more popular recently, small molecules have always acted as the basis for the majority of drug research…
The Importance of Animal Welfare in Preclinical In Vivo Research
October 15, 2019
Until recently, many scientists were convinced that animal welfare and high-quality animal research were not compatible. Animal welfare was considered a nuisance that should…
Working with Families in Pediatric Clinical Drug Trials
October 1, 2019
When designing pediatric clinical drug trials, it’s important to work with the entire family to ensure the experience is convenient, comfortable, and rewarding. If…
Guidance for Scheduling Clinical Trials in Children
September 24, 2019
Children are not little adults, but due to a lack of pediatric clinical trials, children are often prescribed drugs that have only been approved…
New Horizons for Patient Studies at QPS-NL
September 13, 2019
In the pharmaceutical and biotechnology industry more small and even virtual companies are established thereby changing the traditional way of working in early drug…
Solutions for Recruitment for Pediatric Clinical Trials
September 3, 2019
Did you know that only about 20 percent of drugs used today are labeled for pediatric patients? By necessity, products licensed for adults are…
Establishing Preclinical Leadership in Asia with the Addition of Mini Pig Studies
August 19, 2019
Suitable animal models are an unavoidable necessity in the testing and development of new pharmacological agents. QPS has an extensive history of conducting studies…
Establishing Leadership in Asia with SEND
August 12, 2019
As a pioneer with the Standard for Exchange Nonclinical Data (SEND) system in Asia, QPS Taiwan CTPS has taken a leadership role in implementing…
Costly, Life-Changing Type 1 Diabetes Drug Delays Disease, Receives FDA Approval
January 16, 2023
The U.S. Food and Drug Administration has approved teplizumab-mzw (TZIELD™), a drug developed by New Jersey-based Provention Bio to delay the onset of type…
A Breakthrough in Converting Brain Waves to Speech
January 11, 2023
A new pilot study conducted by Chang Lab at UC San Francisco has demonstrated the ability to use new neurotechnology to enable paralyzed individuals…
The Modern Quest for the Fountain of Youth
January 9, 2023
Quests for anti-aging solutions, usually the stuff of science fiction, have been revived with research into cellular reprogramming. More than 15 years ago, researchers…
Attacking KRAS Proteins to Kill Cancer
December 14, 2022
Recent advancements have led to the development of new cancer therapies that target mutations in KRAS proteins, which were once considered untreatable. In 2021,…
Offering Pain Relief Without Opioids, Vertex’s Sodium Channel Blocker Advances
December 12, 2022
Opioid pain relievers are highly addictive, contributing to high rates of opioid use disorder and overdose. According to the World Health Organization, opioid use…
Children with Retinitis Pigmentosa to See the World
December 7, 2022
Retinitis pigmentosa is a degenerative eye condition that slowly destroys the retina, the light-sensitive tissue at the back of the eye. For Canadian couple…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
